Universitat de Barcelona
2022-10-24T12:09:20Z
2023-10-01T05:10:24Z
2022-10-01
2022-10-24T12:09:21Z
Ischemic heart disease (IHD) is the leading global cause of death and is assumed to entail a significant social and economic burden globally. This study aimed to evaluate incidence and mortality trends of IHD in Spain and to estimate direct medical costs (...)
Article
Versió acceptada
Anglès
Política sanitària; Cost de l'assistència sanitària; Mortalitat; Isquèmia; Malalties cardiovasculars; Medical policy; Cost of medical care; Mortality; Ischemia; Cardiovascular diseases
Informa Healthcare
Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2022.2108794
Expert Review of Pharmacoeconomics & Outcomes Research, 2022, vol. 22, num. 7, p. 1147-1152
https://doi.org/10.1080/14737167.2022.2108794
(c) Informa Healthcare, 2022
Economia [1045]
